Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2005
11/10/2005WO2005105835A1 A protein involved in cancer
11/10/2005WO2005105834A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv)
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105143A2 Vaccines and antibodies against ltk for therapy of cancers.
11/10/2005WO2005105142A2 Recombinant reverse transcriptases
11/10/2005WO2005105141A2 Combined meningococcal conjugates with common carrier protein
11/10/2005WO2005105140A2 Meningococcal conjugate vaccination
11/10/2005WO2005105139A2 Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy
11/10/2005WO2005105056A1 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer
11/10/2005WO2005105042A1 Buccal, polar and non-polar sprays containing propofol
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005082408A3 A vaccine composition comprising an immunoadjuvant compound consisting of a rho gtpase family activator
11/10/2005WO2005076975A3 Complexed polypeptide and adjuvant for improved vaccines
11/10/2005WO2005075665A3 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
11/10/2005WO2005070456A3 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
11/10/2005WO2005052002A3 Single-domain antibodies and uses thereof
11/10/2005WO2005049075A3 Compositions and methods for the treatment of tumor of hematopoietic origin
11/10/2005WO2005041890A3 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
11/10/2005WO2005040418A3 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
11/10/2005WO2005032584A3 Pertussis antigens and use thereof in vaccination
11/10/2005WO2005023328A3 Methods for intradermal delivery of therapeutics agents
11/10/2005WO2005018544A8 Therapy-enhancing glucan
11/10/2005WO2005007691A8 East coast fever vaccine based on ctl-specific schizont antigens
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005WO2003106656A3 Single domain tdf-related compounds and analogs thereof
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization
11/10/2005US20050250933 Vaccines
11/10/2005US20050250723 Immunostimulation by chemically modified RNA
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250691 Stimulation of insulin production by injecting a human recombinant GAD65 protein and adjuvant; immunosuppression towards glutamic acid decarboxylase; gene therapy
11/10/2005US20050250689 Antagonists for human prolactin
11/10/2005US20050250688 Adding to blood a deactivated, genetic engineered mutein; anticoagulants
11/10/2005US20050250163 Modulators of angiogenesis and tumorigenesis
11/10/2005US20050250161 inducing tolerance to xenograft tissue or organ; tolerogenic antigen presenting cells (APC) which overexpress monocyte inhibitory receptor (MIR); generating antigen specific allospecific human-suppressor CD8+CD28- T cells; detecting expression of ILT3, ILT4, ILT2 protein; autoimmune diseases; host cell
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050249794 Compositions for stimulating cytokine secretion and inducing an immune response
11/10/2005US20050249756 Use of human prostate cell lines in cancer treatment
11/10/2005US20050249755 Mutant strains of Brucella melitensis and immunogenic compositions
11/10/2005US20050249754 CD4+ T-lymphocyte-specific hepatitis C virus epitopes
11/10/2005US20050249752 Vector for anti-hpv vaccine and transformed microorganism by the vector
11/10/2005US20050249750 Universal T-cell epitopes for anti-malarial vaccines
11/10/2005US20050249749 B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a, pharmaceutical compositions and methods of use
11/10/2005US20050249748 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249745 Papilloma virus truncated L1 protein and fusion protein constructs
11/10/2005US20050249744 Mhc class II haplotype specific immunodominancy of peptides derived from rsv fusion (f) and attachement (g) proteins
11/10/2005US20050249743 Isolated peptides which bind to HLA-A24 molecules and uses thereof
11/10/2005US20050249742 Compositions and methods for modulating a cytotoxic T lymphocyte immune response
11/10/2005US20050249739 Immunoglobulin for treatment and prevention of severe acute respiratory syndrome and/or coronavirus related disorders
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249737 Dendritic cell potentiation
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249735 wherein said anti-TNF alpha antibody competitively inhibits binding of TNF alpha to monoclonal antibody cA2
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods
11/10/2005US20050249733 Mammalian proteases; related reagents
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249726 Useful as therapeutic agent and diagnostic tool for brain tumors which strongly express antigen that is recognized by this antibody
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050249723 Fc polypeptides with novel Fc ligand binding sites
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249721 Compositions and methods for targeted biological delivery of molecular carriers
11/10/2005US20050249711 Allogeneic vaccine and methods to synthesize same
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249704 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050249699 Immunodynamic complexes and methods for using and preparing such complexes
11/10/2005US20050249663 Coadministration of transport protein with conjugated cobalamin to deliver agents
11/10/2005DE10006033B4 Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen Immunizing an individual against carcinomas and their precursors
11/10/2005CA2582265A1 Buccal, polar and non-polar sprays containing propofol
11/10/2005CA2564974A1 Immune response stimulating composition comprising methyl vinyl ether-maleic anhydride copolymer-based nanoparticles
11/10/2005CA2564674A1 Drying process for preserving an active agent as a highly viscous liquid
11/10/2005CA2564596A1 Phep, an amino acid permease of staphylococcus aureus
11/10/2005CA2564512A1 Artificial immune system: methods for making and use
11/10/2005CA2564470A1 Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy
11/10/2005CA2564432A1 Human anti-amyloid .beta. peptide antibody and fragment of said antibody
11/10/2005CA2564366A1 Combined meningococcal conjugates with common carrier protein
11/10/2005CA2564246A1 Compositions and methods for treating immunoproliferatifs disorders such as nk-type ldgl
11/10/2005CA2564244A1 Compositions and methods for enhancing nk cell activity
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2562893A1 Polyvalent viral vectors and a system for production thereof
11/10/2005CA2562181A1 A protein involved in cancer
11/09/2005EP1593738A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier
11/09/2005EP1593691A1 Method of acquiring human monoclonal antibody inhibiting cancer cell proliferation
11/09/2005EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases
11/09/2005EP1593392A1 Rabies vaccine
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592789A2 Administration of transposon-based vectors to reproductive organs
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592724A2 Preparation of polyphosphazene microspheres
11/09/2005EP1592708A2 Therapeutic gpcr targets in cancer
11/09/2005EP1592457A2 Vitamin receptor binding drug delivery conjugates
11/09/2005EP1592449A2 Sensitizing cells for apoptosis by selectively blocking cytokines
11/09/2005EP1592446A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries
11/09/2005EP1592445A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
1 ... 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 ... 1823